Investor Relations
Trading On:
TSX: VPH | OTCQB: VPHIF | FSE: VP2
Valeo Pharma (TSX:VPH) is a Canadian pharmaceutical company focused on the following therapeutic areas: Respiratory/Allergy, Ophthalmology, and Specialty Products. Within these areas Valeo now has 12 commercialized products contributing to significant growth for the coming year.
Investor Relations Contact
Frederic Dumais
Director Communications & Investor Relations
[email protected]
Head Office
16667, Hymus Boul.
Kirkland, Qc
H9H 4R9
Analysts
Scott McAuley
Paradigm Capital
1 (416) 361-9080
Andre Uddin
Research Capital Corporation
1 (416) 860-8675
Stefan Quenneville
Echelon Capital Markets
1 (416) 662-6134
The Newsroom
See all News →